Improving social prescribing effectiveness: enhancing the role of third sector organisations in health and environmental outcomes

提高社会处方有效性：加强第三部门组织在健康和环境成果方面的作用

• 批准号: 2867805
• 金额: --
• 依托单位: University of Bath
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2867805
• 关键词: Improving; social; prescribing; effectiveness; enhancing

Social prescribing is a novel approach that connects primary healthcare with community resources to enhance individuals' wellbeing by addressing practical, social, and emotional needs. Our research operates within this context and seeks to shed light on interactions between key stakeholders and potential outcomes.Research contextSocial prescribing initiatives, notably those running within the UK's National Health Service, involve healthcare professionals referring individuals to link workers, who, in turn, connect them with community resources. The voluntary, community and social enterprise (VCSE) sector plays a pivotal role in providing these community resources, including support groups, physical activities, advocacy, and nature-based interventions. This approach aligns with a shift towards recognising social determinants of health and aims to address overmedication, particularly the rising use of pharmaceuticals impacting individuals as well as the environment, namely through traces in wastewater.Aim, studies and methodsThe aims are twofold:1. Understanding VCSE dynamics: Given the importance of the VCSE sector in social prescribing effectiveness, our first aim is to characterize the interactions between VCSE groups and those referring individuals to them (i.e., link workers) and those influencing their activities (i.e., commissioners).2. Exploring the link between social prescribing and pharmaceuticals: Building on the impact of VCSE activity, our second aim is to examine an underexplored outcome of social prescribing - its potential influence on pharmaceutical prescriptions and its environmental implications.These will be addressed through four studies. Firstly, a review which will document experiences of VCSE organisations within social prescribing provision, including funding challenges and outcomes evaluated. Secondly, we will conduct interviews with VCSE representatives to explore barriers and facilitators in their interactions and potential social prescribing outcomes, including environmental impacts. Thirdly, building on the two prior studies, paired interviews combining VCSE representatives with either link workers or commissioners exploring their respective remits within the social prescribing system. At present, I anticipate the final study will be an analysis of secondary data provided by a GP surgery to explore the impact of social prescribing on wellbeing and medication use, considering pharmaceutical residue in wastewater.Planned CollaborationTo address the interdisciplinary nature of this research, we have assembled a team of supervisors and collaborators with expertise in environmental impacts, social and health psychology, and social prescribing design and delivery. External collaborators include Wessex Water, Bath & North East Somerset council, and a local BANES Medical Practice. Given the newness and evolving nature of social prescribing, an overseas institutional visit is planned to gain insights on practice in this field.Potential applications and benefitsThis research addresses a gap in social prescribing studies by emphasising VCSE perspective and their funding and evaluation requirements alongside potential longer-term health and environmental outcomes. I anticipate that the results of the planned studies have several potential applications and benefits:- Enhancing social prescribing effectiveness by understanding dynamics between key stakeholders to maximise VCSE potential.- Potential for reducing pharmaceutical over-prescription by identifying the relationship between social prescribing and pharmaceutical use to benefit individuals and the environment.- Environmental sustainability by offering insights into how social prescribing can contribute to environmental sustainability by reducing pharmaceutical residues in wastewater.This research aligns with evolving social prescribing research trends and aims to inform policy and delivery in this area.

社会处方是一种新颖的方法，它将主要的医疗保健与社区资源联系起来，通过满足实际，社会和情感需求来增强个人的福祉。我们的研究在这种情况下运作，并试图阐明主要利益相关者与潜在结果之间的互动。研究环境的处方倡议，尤其是那些在英国国家卫生服务中运行的计划，涉及医疗保健专业人员将个人推荐给个人来联系，他们将工作人员链接到联系人，他们又依次联系，相互联系，相互联系，而他们又依次联系，他们又依次连接，相互联系，相互联系。他们拥有社区资源。自愿，社区和社会企业（VCSE）部门在提供这些社区资源（包括支持小组，体育活动，倡导和基于自然的干预措施）方面发挥了关键作用。这种方法与认识到健康的社会决定因素的转变相吻合，并旨在解决过度用药，尤其是对影响个人和环境的药物的使用不断上升，即通过废水痕迹。IAM.AIM，研究和方法，目的是双重的：1。了解VCSE动态：鉴于VCSE部门在社会处方有效性中的重要性，我们的第一个目的是表征VCSE组与将个人转介的人（即链接工人）和影响其活动（即专员）的人之间的相互作用。 2。探索社会处方与药品之间的联系：基于VCSE活动的影响，我们的第二个目的是检查社会处方的不足结果 - 其对药物处方及其环境影响的潜在影响。这些将通过四项研究来解决。首先，一项审查将记录社会处方规定中VCSE组织的经验，包括评估的挑战和成果。其次，我们将对VCSE代表进行采访，以探索其互动和潜在的社会处方结果（包括环境影响）的障碍和促进者。第三，在两项先前的研究基础上，将VCSE代表与链接工人或专员探索各自的社会处方系统中汇款的访谈配对。目前，我预计最终研究将是对GP手术提供的二级数据的分析，以探讨社会处方对福祉和用药使用的影响，考虑到废水中的药物残留物。计划协作以解决这项研究的跨学科性质，我们已经组建了一个主管和合作者团队，具有环境影响，社会和健康心理学以及社会处方设计和交付方面的专业知识。外部合作者包括Wessex Water，Bath＆Bath and North East Somerset Council，以及当地的BANES医疗实践。鉴于社会处方的新颖性和不断发展的性质，计划进行海外机构访问，以在该领域的实践中获得见解。潜力申请和福利这一研究解决了社会处方研究的差距，通过强调VCSE的观点及其资金和他们的资金和评估要求以及潜在的更长的评估要求 - 期健康和环境成果。我预计计划研究的结果具有多种潜在的应用和好处： - 通过了解主要利益相关者之间的动态以最大化VCSE潜力来提高社会处方效率。通过洞悉社会处方如何通过减少废水中的药物残留物来促进环境可持续性的洞察力，这与不断发展的社会处方研究趋势相结合，并旨在为该领域的政策和交付提供信息。